Lack of Access to Antibiotics Becoming a Serious Global Health Issue

Photo of author

( — January 12, 2022) Orlando, FL — Over decades, experts have been warning against the impacts of antibiotic resistance, which results from overuse and misuse of antibiotics. 

While this is a major health challenge, it is also worth noting that many in the low- and middle-income countries die due to lack of access to antibiotics. 

Research has shown that a majority of the global annual 5.7 million antibiotic-treatable deaths happen in low- and middle-income countries. These are areas where the mortality burden from treatable bacterial infections significantly exceeds the estimated annual 700,000 deaths due to antibiotic-resistant infections.

A new report titled “Access Barriers to Antibiotics” was made by researchers at the Center for Disease Dynamics, Economics & Policy (CDDEP).

It involved stakeholder interviews in Uganda, India, and Germany.

According to Dr. Ramanan Laxminarayan, lack of access to antibiotics kills more people currently than antibiotic resistance, but we have not had a good handle on why these barriers are created.

Dr. Laxminarayan is the CDDEP director and a co-author of the report. 

The findings of this report have revealed that even after the discovery of a new antibiotic, widespread market entry, as well as drug availability, was still altogether prevented by regulatory hurdles and substandard health facilities delay.

“Our research shows that of 21 new antibiotics entering markets between 1999 and 2014, less than five were registered in most countries in sub-Saharan Africa. Just the mere existence of an effective antibiotic does not mean that they are available in countries where they are most needed,” he adds.

The demand for antibiotics continues to increase as the rates of infections like UTIs skyrocket. It is important to note that misuse and overuse of this medication are closely linked with side effects. 

One of the strong recommendations to reduce or eliminate the need for antibiotics is to inhibit the onset of conditions requiring its use. 

To reduce the odds of UTIs, it is wise to consume more water as this helps flush bacteria out of the body. There is also another way to ward off infection and one is to use D-mannose, which is a therapeutic sugar that can be found in cranberry.

It works like a magnet to the E.coli bacteria that account for 90 percent of all UTIs. 

Today, formulas like Divine Bounty D-mannose are widely resorted to by individuals who suffer from the infection. This is a carefully crafted supplement that has added ingredients like cranberry and dandelion extracts.

Divine Bounty D-mannose is made carefully in an FDA-inspected facility in the U.S. (


Purest Vantage is passionate and dedicated to developing high-quality products that assist people in maintaining optimal health, enabling them to enjoy all the benefits a healthy lifestyle offers.


390 North Orange Avenue
Suite 2300-C
Orlando, FL 32801
United States